The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Peptide Mapping Identifies Hotspot Site of Modification in Human Serum Albumin by Methylglyoxal Involved in Ligand Binding and Esterase Activity
Open accessAbstract
Methylglyoxal is a potent glycating agent under physiological conditions. Human serum albumin is modified by methylglyoxal in vivo. The glycation adducts formed and structural and functional changes induced by methylglyoxal modification have not been fully disclosed. Methylglyoxal reacted with human serum albumin under physiological conditions to form mainly the hydroimidazolone N(delta)-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (92% of total modification) with a minor formation of argpyrimidine, N(epsilon)-(1-carboxyethyl)lysine, and methylglyoxal lysine dimer. When human serum albumin was modified minimally with methylglyoxal, tryptic peptide mapping indicated a hotspot of modification at Arg-410 located in drug-binding site II and the active site of albumin-associated esterase activity. Modification of Arg-410 by methylglyoxal was found in albumin glycated in vivo. Other sites of minor modification were: Arg-114, Arg-186, Arg-218, and Arg-428. Hydroimidazolone formation at Arg-410 inhibited ketoprofen binding and esterase activity; correspondingly, glycation in the presence of ketoprofen inhibited Arg-410 modification and loss of esterase activity. The pH dependence of esterase activity indicated a catalytic group with pK(a) = 7.9 +/- 0.1, assigned to the catalytic base Tyr-411 with the conjugate base stabilized by interaction with the guanidinium group of Arg-410. Modification by methylglyoxal destabilized Tyr-411 and increased the pK(a) to 8.8 +/- 0.1. Molecular dynamics and modeling studies indicated that hydroimidazolone formation caused structural distortion leading to disruption of arginine-directed hydrogen bonding and loss of electrostatic interactions. Methylglyoxal modification of critical arginine residues, therefore, whether experimental or physiological, is expected to disrupt protein-ligand interactions and inactivate enzyme activity by hydroimidazolone formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atomic structure and chemistry of human serum albumin
He, X. M., & Carter, D. C. (1992) · Nature · doi:10.1038/358209a0 · Cited by 3,824
Protein degradation and protection against misfolded or damaged proteins.
Goldberg, A. L. (2003) · Nature · doi:10.1038/nature02263 · Cited by 2,088
Crystal structure of human serum albumin at 2.5 Å resolution
Sugio, S., Kashima, A., Mochizuki, S., Noda, M., & Kobayashi, K. (1999) · Protein Engineering, Design and Selection · doi:10.1093/protein/12.6.439 · Cited by 1,786
Curry, S., Mandelkow, H., Brick, P., & Franks, N. (1998) · Nature Structural Biology · doi:10.1038/1869 · Cited by 1,377
Generalized Born Models of Macromolecular Solvation Effects
Bashford, D., & Case, D. A. (2000) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.51.1.129 · Cited by 1,146
Bhattacharya, A. A., Grüne, T., & Curry, S. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4158 · Cited by 905
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.
Kragh-Hansen, U., Chuang, V. T. G., & Otagiri, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.695 · Cited by 892
Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin
Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., & Curry, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100575200 · Cited by 825
Madura, J. D., Briggs, J. M., Wade, R. C., Davis, M. E., Luty, B. A., Ilin, A., Antosiewicz, J., Gilson, M. K., Bagheri, B., Scott, L. R., et al. (1995) · Computer Physics Communications · doi:10.1016/0010-4655(95)00043-f · Cited by 808
THORNALLEY, P. J., BATTAH, S., AHMED, N., KARACHALIAS, N., AGALOU, S., BABAEI-JADIDI, R., & DAWNAY, A. (2003) · Biochemical Journal · doi:10.1042/bj20030763 · Cited by 659
Self-citation
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
Li, B., Sedlacek, M., Manoharan, I., Boopathy, R., Duysen, E. G., Masson, P., & Lockridge, O. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.002 · Cited by 540
Bierhaus, A., Fleming, T., Stoyanov, S., Leffler, A., Babes, A., Neacsu, C., Sauer, S. K., Eberhardt, M., Schnölzer, M., Lasitschka, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2750 · Cited by 495
Self-citationThornalley (2008) · Drug Metabolism and Drug Interactions · doi:10.1515/dmdi.2008.23.1-2.125 · Cited by 480
Specific antioxidant properties of human serum albumin
Taverna, M., Marie, A.-L., Mira, J.-P., & Guidet, B. (2013) · Annals of Intensive Care · doi:10.1186/2110-5820-3-4 · Cited by 473
The glycation of albumin: Structural and functional impacts
Rondeau, P., & Bourdon, E. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.003 · Cited by 433
Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome
Rabbani, N., & Thornalley, P. J. (2012) · Amino Acids · doi:10.1007/s00726-010-0783-0 · Cited by 430
Self-citationZhang, Q., Ames, J. M., Smith, R. D., Baynes, J. W., & Metz, T. O. (2009) · Journal of Proteome Research · doi:10.1021/pr800858h · Cited by 421
Review: Glycation of human serum albumin
Anguizola, J., Matsuda, R., Barnaby, O. S., Hoy, K. S., Wa, C., DeBolt, E., Koke, M., & Hage, D. S. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.07.013 · Cited by 395
Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed, N., & Thornalley, P. J. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00595.x · Cited by 371
Self-citationStructural and biochemical features of human Serum albumin essential for eukaryotic cell culture
Mishra, V., & Heath, R. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168411 · Cited by 295
“Albumin glycation occurs when the amino group of a basic residue forms a Schiff base with a sugar carbonyl group [97,98].”
BackgroundDobler, D., Ahmed, N., Song, L., Eboigbodin, K. E., & Thornalley, P. J. (2006) · Diabetes · doi:10.2337/db05-1634 · Cited by 270
Self-citationReview: Modifications of Human Serum Albumin and their Binding Effect
Lee, P., & Wu, X. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150302115025 · Cited by 269
The glyoxalase pathway: the first hundred years… and beyond
Sousa Silva, M., Gomes, R. A., Ferreira, A. E. N., Ponces Freire, A., & Cordeiro, C. (2013) · Biochemical Journal · doi:10.1042/bj20121743 · Cited by 256
Alderson, N. L., Wang, Y., Blatnik, M., Frizzell, N., Walla, M. D., Lyons, T. J., Alt, N., Carson, J. A., Nagai, R., Thorpe, S. R., et al. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.03.005 · Cited by 202
Xue, J., Ray, R., Singer, D., Böhme, D., Burz, D. S., Rai, V., Hoffmann, R., & Shekhtman, A. (2014) · Biochemistry · doi:10.1021/bi500046t · Cited by 186
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
Rabbani, N., Xue, M., & Thornalley, P. J. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9705-z · Cited by 169
Self-citationDicarbonyl proteome and genome damage in metabolic and vascular disease
Rabbani, N., & Thornalley, P. J. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140018 · Cited by 140
Self-citationThornalley, P. J., & Rabbani, N. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.025 · Cited by 133
Self-citationGlyoxalase 1 Modulation in Obesity and Diabetes
Rabbani, N., & Thornalley, P. J. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7424 · Cited by 102
Self-citationRabbani, N., Xue, M., Weickert, M. O., & Thornalley, P. J. (2021) · Nutrients · doi:10.3390/nu13072374 · Cited by 74
Self-citationOxidation of Arg‐410 promotes the elimination of human serum albumin
Iwao, Y., Anraku, M., Yamasaki, K., Kragh-Hansen, U., Kawai, K., Maruyama, T., & Otagiri, M. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.01.011 · Cited by 53
Glycation free adduct accumulation in renal disease: the new AGE
Thornalley, P. J. (2005) · Pediatric Nephrology · doi:10.1007/s00467-005-2011-9 · Cited by 53
Metadata
- Authors
- Ahmed, N., Dobler, D., Dean, M., & Thornalley, P. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 280
- Issue
- 7
- Pages
- 5724-5732
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2006297498
- Cited by
- 314
- References
- 37
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.